- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Diet and the gut microbiome in patients with Parkinson’s disease ; volume:10 ; number:1 ; day:22 ; month:4 ; year:2024 ; pages:1-9 ; date:12.2024
npj Parkinson's Disease ; 10, Heft 1 (22.4.2024), 1-9, 12.2024
- Urheber
-
Kwon, Dayoon
Zhang, Keren
Paul, Kimberly C.
Folle, Aline D.
Rosario, Irish Del
Jacobs, Jonathan P.
Keener, Adrienne M.
Bronstein, Jeff M.
Ritz, Beate
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41531-024-00681-7
- URN
-
urn:nbn:de:101:1-2407082111513.882789397462
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kwon, Dayoon
- Zhang, Keren
- Paul, Kimberly C.
- Folle, Aline D.
- Rosario, Irish Del
- Jacobs, Jonathan P.
- Keener, Adrienne M.
- Bronstein, Jeff M.
- Ritz, Beate
- SpringerLink (Online service)
Ähnliche Objekte (12)
Microbiome changes: an indicator of Parkinson’s disease?
Study of the gut microbiome in Egyptian patients with Parkinson’s Disease
Correction: Study of the gut microbiome in Egyptian patients with Parkinson’s Disease
Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease
Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
Patients’ experiences of Parkinson’s disease: a qualitative study in glucocerebrosidase and idiopathic Parkinson’s disease
Drug therapy in patients with Parkinson’s disease
Apolipoprotein D concentration in Parkinson’s disease patients
Gut microbiome is not associated with mild cognitive impairment in Parkinson’s disease
Oral and gut microbiome profiles in people with early idiopathic Parkinson’s disease
The Parkinson’s disease drug entacapone disrupts gut microbiome homeostasis via iron sequestration
Microbiome changes: an indicator of Parkinson’s disease?
Study of the gut microbiome in Egyptian patients with Parkinson’s Disease
Correction: Study of the gut microbiome in Egyptian patients with Parkinson’s Disease
Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease
Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
Patients’ experiences of Parkinson’s disease: a qualitative study in glucocerebrosidase and idiopathic Parkinson’s disease
Drug therapy in patients with Parkinson’s disease
Apolipoprotein D concentration in Parkinson’s disease patients
Gut microbiome is not associated with mild cognitive impairment in Parkinson’s disease
Oral and gut microbiome profiles in people with early idiopathic Parkinson’s disease
The Parkinson’s disease drug entacapone disrupts gut microbiome homeostasis via iron sequestration
Microbiome changes: an indicator of Parkinson’s disease?
Study of the gut microbiome in Egyptian patients with Parkinson’s Disease
Correction: Study of the gut microbiome in Egyptian patients with Parkinson’s Disease
Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease
Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
Patients’ experiences of Parkinson’s disease: a qualitative study in glucocerebrosidase and idiopathic Parkinson’s disease
Drug therapy in patients with Parkinson’s disease
Apolipoprotein D concentration in Parkinson’s disease patients
Gut microbiome is not associated with mild cognitive impairment in Parkinson’s disease
Oral and gut microbiome profiles in people with early idiopathic Parkinson’s disease